{{medical}}
{{drugbox | verifiedrevid = 411133087
| IUPAC_name = (1-methyl-4-phenylpiperidin-4-yl) propanoate
| image = MPPP.svg
| width = 200px
<!--Clinical data-->
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- Schedule I -->
| legal_UK = <!-- Class A -->
| legal_US = Schedule I
| legal_status = 
| routes_of_administration = 
<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
<!--Identifiers-->
| CAS_number = 13147-09-6
| CAS_number_Ref = {{cascite|correct|CAS}}
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 61583
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01478
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 55493
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 279865
<!--Chemical data-->
| C=15 | H=21 | N=1 | O=2 
| molecular_weight = 247.33 g/mol
| smiles = O=C(OC2(c1ccccc1)CCN(C)CC2)CC
| InChI = 1/C15H21NO2/c1-3-14(17)18-15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3
| InChIKey = BCQMRZRAWHNSBF-UHFFFAOYAP
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C15H21NO2/c1-3-14(17)18-15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BCQMRZRAWHNSBF-UHFFFAOYSA-N
| synonyms = 4-propionyloxy-4-phenyl-N-methylpiperidine, MPPP, 3-desmethylprodine
}}

'''1-甲基-4-苯基-4-哌啶丙酸酯'''（'''MPPP'''）是一种在1940年代由[[罗氏|罗氏]]的研发人员研制出来的[[鴉片類藥物|鸦片类]][[止痛药|止痛药]]。<ref>US Patent 2498432 - I. Branched Lower Alkyl-4-Phenyl-4-Aceloxy Piperidines</ref> MPPP后来在[[医学|医学]]上并没有被使用，不过却被作为一种[[毒品|毒品]]而非法生产。它是一种[[哌替啶|哌替啶]]的类似物，但由于在医学上没有用途，[[美国缉毒局|美国缉毒局]]的受控物质法案将其列为了I类管制药物。实际上MPPP是哌替啶酯的羧酸部分与醇部分调转的[[同分异构体|同分异构体]]，被认为有相当于[[吗啡|吗啡]]的70%的药效。

这种药物在1977年由一名23岁的[[马里兰州|马里兰州]][[化学|化学]]系学生巴里·金德斯顿（Barry Kidston）第一次作为毒品合成。金德斯顿当时参考了阿尔伯特·耶林的一篇[[论文|论文]]。<ref>{{Cite journal| pmid = 18919744 | year = 1947 | last1 = Ziering | first1 = A. | last2 = Lee| title = Piperidine derivatives; 1,3-dialkyl-4-aryl-4-acyloxypiperidines | volume = 12 | issue = 6 | pages = 911–914 | journal = The Journal of organic chemistry | doi = 10.1021/jo01170a024 | first2 = J. }}</ref> 通过将杜冷丁的酯结构反转，他成功制造出了MPPP这种在当时合法且不受控制的接近吗啡的药效的毒品。

然而，合成时一种三级[[醇|醇]]的中间产物在超过30°C的[[酸性|酸性]]环境下极其容易[[脱水|脱水]]。金德斯顿当时并没有预料到这一点——因此他直接在常温下用[[丙酸酐|丙酸酐]]酯化了这种中间产物，从而导致合成出来的MPPP含有大量杂质[[MPTP|MPTP]]。<ref>{{Cite journal | pmid = 6148225 
| year = 1984 | last1 = Johannessen | first1 = J. N. | last2 = Markey| title = Assessment of the opiate properties of two constituents of a toxic illicit drug mixture | volume = 13 | issue = 4 | pages = 367–374 | journal = Drug and alcohol dependence | doi = 10.1016/0376-8716(84)90004-8 | first2 = S. P. }}</ref> 在金德斯顿给自己注射这种不纯的毒品的数天之后，他和几个一起试用这些MPPP的朋友开始出现严重的[[帕金森氏症|帕金森氏症]]的症状。<ref>Gibb, Barry J. (2007). ''The Rough Guide to the Brain'', Rough Guides Ltd., London, pg.166</ref>

1-甲基-4-苯基吡啶（[[MPP+|MPP+]]），一种MPTP的代谢产物，能够引起类似帕金森病的不可逆症状的急性发作。<ref>{{Cite journal | pmid = 298352 | year = 1979 | last1 = Davis | first1 = G. C. | last2 = Williams | last3 = Markey | last4 = Ebert | last5 = Caine | last6 = Reichert | last7 = Kopin | title = Chronic Parkinsonism secondary to intravenous injection of meperidine analogues | volume = 1 | issue = 3 | pages = 249–254 | journal = Psychiatry research | doi = 10.1016/0165-1781(79)90006-4 | first2 = A. C. | first3 = S. P. | first4 = M. H. | first5 = E. D. | first6 = C. M. | first7 = I. J. }}</ref><ref name="urlSurprising Clue to Parkinsons - TIME">{{cite news |url=http://www.time.com/time/magazine/article/0,9171,1101850408-141542,00.html |title=Surprising Clue to Parkinson's - TIME |work=Time |accessdate=2010-05-13 |date=2001-06-24 |first=Claudia |last=Wallis |archive-date=2010-06-12 |archive-url=https://web.archive.org/web/20100612214331/http://www.time.com/time/magazine/article/0,9171,1101850408-141542,00.html |dead-url=no }}</ref> 当MPTP进入大脑之后，会被[[神經膠質細胞|神經膠質細胞]]里的[[单胺氧化酶|单胺氧化酶B]][[代谢|代谢]]成MPP+这种[[神经毒素|神经毒素]]。MPP+随即选择性地杀死大脑中{{Link-en|黑质致密部|pars compacta}}产生多巴胺的神经细胞，进而引发帕金森氏症。<ref>{{Cite journal | pmid = 11768626 | year = 2001 | last1 = Schmidt | first1 = N. | last2 = Ferger | title = Neurochemical findings in the MPTP model of Parkinson's disease | volume = 108 | issue = 11 | pages = 1263–1282 | journal = Journal of neural transmission (Vienna, Austria : 1996) | doi = 10.1007/s007020100004 | first2 = B. }}</ref>

== 参考资料 ==
{{reflist}}

[[Category:合成阿片样物质|Category:合成阿片样物质]]
[[Category:丙酸酯|Category:丙酸酯]]
[[Category:哌啶|Category:哌啶]]
[[Category:Μ-阿片激动剂|Category:Μ-阿片激动剂]]
[[Category:狡詐家藥物|Category:狡詐家藥物]]